Anavex Life Sciences Corp (0HFR.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 4,500,000 2,621,000 3,146,000 2,781,000
Operating Expenses 14,459,000 12,513,000 13,592,000 14,336,000
Operating Income -14,459,000 -12,513,000 -13,592,000 -14,336,000
Interest Expense 0 0 0 0
Income Before Tax -13,370,000 -11,292,000 -12,523,000 -11,744,000
Income Tax Expense -127,000 -96,000 -412,000 -124,000
Net Income 0 -11,196,000 -12,111,000 -11,620,000
Per Share
EPS -0.16 -0.13 -0.14 -0.14
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-09-30 2023-09-30 2022-09-30
Revenue 0 0 0
Cost of Revenue 0 0 0
Gross Profit 0 0 0
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 11,039,000 12,039,000 13,070,068
Operating Expenses 52,877,000 55,756,000 50,985,815
Operating Income -52,877,000 -55,756,000 -50,985,820
Interest Expense 0 964,000 0
Income Before Tax -43,002,000 -47,498,000 -50,942,438
Income Tax Expense -2,291,000 7,000 -2,964,519
Net Income -43,002,000 -47,505,000 -47,977,919
Per Share
EPS -0.52 -0.60 -0.62
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-09-30 2023-09-30 2022-09-30
Assets
Cash and Cash Equivalents 132,187,000 151,024,000 149,157,861
Short Term Investments 0 0 0
Net Receivables 2,449,000 2,709,000 3,192,580
Inventory 0 0 0
Total Current Assets 135,567,000 154,386,000 152,704,603
Property Plant Equipment 0 0 0
Goodwill and Intangibles 0 0 0
Total Assets 135,567,000 154,386,000 152,704,603
Liabilities
Account Payables 9,627,000 4,322,000 3,824,777
Short Term Debt 0 0 0
Total Current Liabilities 15,304,000 12,534,000 10,213,561
Long Term Debt 0 0 0
Total Liabilities 15,304,000 12,534,000 10,213,561
Shareholders Equity
Retained Earnings -336,071,000 -293,069,000 -245,563,783
Total Shareholders Equity 120,263,000 141,852,000 142,491,042
Balance Sheet (Annual) 2024-09-30 2023-09-30 2022-09-30
Assets
Cash and Cash Equivalents 132,187,000 151,024,000 149,157,861
Short Term Investments 0 0 0
Net Receivables 2,449,000 2,709,000 3,192,580
Inventory 0 0 0
Total Current Assets 135,567,000 154,386,000 152,704,603
Property Plant Equipment 0 0 0
Goodwill and Intangibles 0 0 0
Total Assets 135,567,000 154,386,000 152,704,603
Liabilities
Account Payables 9,627,000 4,322,000 3,824,777
Short Term Debt 0 0 0
Total Current Liabilities 15,304,000 12,534,000 10,213,561
Long Term Debt 0 0 0
Total Liabilities 15,304,000 12,534,000 10,213,561
Shareholders Equity
Retained Earnings -336,071,000 -293,069,000 -245,563,783
Total Shareholders Equity 120,263,000 141,852,000 142,491,042
Cash Flow Statement (Quarterly) 2024-09-30 2023-09-30 2022-09-30
Operating Activities
Net Income -43,002,000 -47,505,000 -47,977,919
Depreciation & Amortization 0 0 0
Stock Based Compensation 9,438,000 16,370,000 18,379
Change in Working Capital 2,752,000 2,505,000 5,360,813
Operating Cash Flow -30,812,000 -27,785,000 -24,237,864
Investing Activities
Capital Expenditure 0 0 0
Investments 0 0 0
Investing Cash Flow 0 0 0
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 11,284,000 27,875,000 21,287,980
Dividends Paid 0 0 0
Financing Cash Flow 11,975,000 29,651,000 21,287,980
Summary
Free Cash Flow -30,812,000 -27,785,000 -24,237,864
Net Change in Cash -18,837,000 1,866,000 -2,949,884
Cash Flow Statement (Annual) 2024-09-30 2023-09-30 2022-09-30
Operating Activities
Net Income -43,002,000 -47,505,000 -47,977,919
Depreciation & Amortization 0 0 0
Stock Based Compensation 9,438,000 16,370,000 18,379
Change in Working Capital 2,752,000 2,505,000 5,360,813
Operating Cash Flow -30,812,000 -27,785,000 -24,237,864
Investing Activities
Capital Expenditure 0 0 0
Investments 0 0 0
Investing Cash Flow 0 0 0
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 11,284,000 27,875,000 21,287,980
Dividends Paid 0 0 0
Financing Cash Flow 11,975,000 29,651,000 21,287,980
Summary
Free Cash Flow -30,812,000 -27,785,000 -24,237,864
Net Change in Cash -18,837,000 1,866,000 -2,949,884